IL-21 has been studied in preclinical models of cancer pertaining to the maintenance of antigen-specific CD8 T-cell responses [24], as well as in relation to the proliferation, survival and functionality of cancer-specific T cells isolated from patients with melanoma or pancreatic cancer [22, 25]. Here, CD8A is linked to familial pancreatic carcinoma.